{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:01:48Z","timestamp":1790694108778,"version":"4.1.0"},"reference-count":178,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","award":["758"],"award-info":[{"award-number":["758"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.bbagen.2018.08.019","type":"journal-article","created":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T14:53:37Z","timestamp":1535640817000},"page":"2955-2965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Nanobodies as novel therapeutic agents in envenomation"],"prefix":"10.1016","volume":"1862","author":[{"given":"Ehsan","family":"Alirahimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Kazemi-Lomedasht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delavar","family":"Shahbazzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Habibi-Anbouhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Hosseininejad Chafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazli","family":"Sotoudeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajarossadat","family":"Ghaderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Muyldermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Behdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2018.08.019_bb0005","series-title":"WHO Guidelines for the Production, Control and Regulation of Snake Antivenom Immunoglobulins","first-page":"134","author":"W. World Health Organization","year":"2010"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0010","doi-asserted-by":"crossref","first-page":"447","DOI":"10.15171\/ijhpm.2015.75","article-title":"Needs and availability of snake antivenoms: relevance and application of international guidelines","volume":"4","author":"Scheske","year":"2015","journal-title":"Int. J. Health Policy Manag."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0015","doi-asserted-by":"crossref","first-page":"17063","DOI":"10.1038\/nrdp.2017.63","article-title":"Snakebite envenoming","volume":"3","author":"Gutierrez","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0020","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0022-3476(05)83196-8","article-title":"Scorpion envenomation and antivenom therapy","volume":"124","author":"Sofer","year":"1994","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.actatropica.2008.05.021","article-title":"Epidemiology of scorpionism: a global appraisal","volume":"107","author":"Chippaux","year":"2008","journal-title":"Acta Trop."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/toxins8080226","article-title":"Biotechnological trends in spider and scorpion antivenom development","volume":"8","author":"Laustsen","year":"2016","journal-title":"Toxins"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0035","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.jprot.2011.06.019","article-title":"Research strategies to improve snakebite treatment: challenges and progress","volume":"74","author":"Harrison","year":"2011","journal-title":"J. Proteome"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0040","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1146\/annurev-immunol-051116-052433","article-title":"Signaling by antibodies: recent progress","volume":"35","author":"Bournazos","year":"2017","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/07388551.2015.1114465","article-title":"Anti-Ebola therapies based on monoclonal antibodies: current state and challenges ahead","volume":"37","author":"Gonz\u00e1lez-Gonz\u00e1lez","year":"2017","journal-title":"Crit. Rev. Biotechnol."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/imr.12484","article-title":"Identification and specificity of broadly neutralizing antibodies against HIV","volume":"275","author":"McCoy","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0055","article-title":"Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients","volume":"1","author":"Hill","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0060","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jprot.2015.07.015","article-title":"Cobra venom proteome and glycome determined from individual snakes of Naja atra reveal medically important dynamic range and systematic geographic variation","volume":"128","author":"Huang","year":"2015","journal-title":"J. Proteome"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0065","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3390\/toxins5020203","article-title":"Interactions of PLA2-s from Vipera lebetina, Vipera berus berus and Naja naja oxiana venom with platelets, bacterial and cancer cells","volume":"5","author":"Samel","year":"2013","journal-title":"Toxins"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0070","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jprot.2016.12.018","article-title":"Proteomic analysis to unravel the complex venom proteome of eastern India Naja naja: correlation of venom composition with its biochemical and pharmacological properties","volume":"156","author":"Dutta","year":"2017","journal-title":"J. Proteome"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0075","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.toxicon.2012.09.009","article-title":"A brief review of the scientific history of several lesser-known snake venom proteins: l-amino acid oxidases, hyaluronidases and phosphodiesterases","volume":"62","author":"Fox","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2164-12-1","article-title":"Venom gland transcriptomes of two elapid snakes (Bungarus multicinctus and Naja atra) and evolution of toxin genes","volume":"12","author":"Jiang","year":"2011","journal-title":"BMC Genomics"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0085","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1186\/1471-2164-10-564","article-title":"Comparative venom gland transcriptome surveys of the saw-scaled vipers (Viperidae: Echis) reveal substantial intra-family gene diversity and novel venom transcripts","volume":"10","author":"Casewell","year":"2009","journal-title":"BMC Genomics"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0090","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jprot.2008.05.003","article-title":"Snake venomics of the Armenian mountain vipers Macrovipera lebetina obtusa and Vipera raddei","volume":"71","author":"Sanz","year":"2008","journal-title":"J. Proteome"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0095","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/pmic.200700777","article-title":"Exploring snake venom proteomes: multifaceted analyses for complex toxin mixtures","volume":"8","author":"Fox","year":"2008","journal-title":"Proteomics"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0100","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/toxins9090290","article-title":"A review and database of snake venom proteomes","volume":"9","author":"Tasoulis","year":"2017","journal-title":"Toxins"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0105","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3390\/molecules22081305","article-title":"Structures and functions of snake venom metalloproteinases (SVMP) from protobothrops venom collected in Japan","volume":"22","author":"Oyama","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0110","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3390\/toxins8080230","article-title":"Colubrid venom composition: an-omics perspective","volume":"8","author":"Junqueira-de-Azevedo","year":"2016","journal-title":"Toxins"},{"issue":"Suppl. 2","key":"10.1016\/j.bbagen.2018.08.019_bb0115","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/jnc.13975","article-title":"The three-finger toxin fold: a multifunctional structural scaffold able to modulate cholinergic functions","volume":"142","author":"Kessler","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0120","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2148-8-70","article-title":"Unusual accelerated rate of deletions and insertions in toxin genes in the venom glands of the pygmy copperhead (Austrelaps labialis) from Kangaroo island","volume":"8","author":"Doley","year":"2008","journal-title":"BMC Evol. Biol."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0125","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1074\/mcp.M700094-MCP200","article-title":"Evolution of an arsenal structural and functional diversification of the venom system in the advanced snakes (Caenophidia)","volume":"7","author":"Fry","year":"2008","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0130","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s00239-003-2497-3","article-title":"Isolation of a neurotoxin (\u03b1-colubritoxin) from a nonvenomous colubrid: evidence for early origin of venom in snakes","volume":"57","author":"Fry","year":"2003","journal-title":"J. Mol. Evol."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0135","doi-asserted-by":"crossref","first-page":"29030","DOI":"10.1074\/jbc.M605850200","article-title":"Denmotoxin, a three-finger toxin from the colubrid snake Boiga dendrophila (Mangrove Catsnake) with bird-specific activity","volume":"281","author":"Pawlak","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0140","series-title":"Doklady Biochemistry and Biophysics","first-page":"294","article-title":"Nonconventional three-finger toxin BMLCL from krait Bungarus multicinctus venom with high affinity interacts with nicotinic acetylcholine receptors","volume":"vol. 464","author":"Utkin","year":"2015"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048112","article-title":"Identification and structural characterization of a new three-finger toxin hemachatoxin from Hemachatus haemachatus venom","volume":"7","author":"Girish","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0150","doi-asserted-by":"crossref","first-page":"19694","DOI":"10.1074\/jbc.270.34.19694","article-title":"Fasciculin 2 binds to the peripheral site on acetylcholinesterase and inhibits substrate hydrolysis by slowing a step involving proton transfer during enzyme acylation","volume":"270","author":"Eastman","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0155","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1073\/pnas.88.6.2437","article-title":"Calciseptine, a peptide isolated from black mamba venom, is a specific blocker of the L-type calcium channel","volume":"88","author":"de Weille","year":"1991","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0160","first-page":"287","article-title":"FS2. A mamba venom toxin, is a specific blocker of the L-type calcium channels","volume":"21","author":"Yasuda","year":"1994","journal-title":"Artery"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0165","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1096\/fj.07-8658com","article-title":"\u03b2-Cardiotoxin: a new three-finger toxin from Ophiophagus hannah (king cobra) venom with beta-blocker activity","volume":"21","author":"Rajagopalan","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0170","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.3390\/toxins5122533","article-title":"Secreted phospholipases A2 of snake venoms: effects on the peripheral neuromuscular system with comments on the role of phospholipases A2 in disorders of the CNS and their uses in industry","volume":"5","author":"Harris","year":"2013","journal-title":"Toxins"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0175","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0163-7258(94)90049-3","article-title":"Hemorrhagic metalloproteinases from snake venoms","volume":"62","author":"Bjarnason","year":"1994","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0180","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1590\/S0100-879X1998000700001","article-title":"Snake venom metalloproteinases and disintegrins: interactions with cells","volume":"31","author":"Kamiguti","year":"1998","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10408449991349168","article-title":"Snake venom hemorrhagins","volume":"29","author":"Hati","year":"1999","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0041-0101(94)00138-X","article-title":"Isolation and characterization of a metalloproteinase with weak hemorrhagic activity from the venom of the snake Bothrops asper (terciopelo)","volume":"33","author":"Guti\u00e9rrez","year":"1995","journal-title":"Toxicon"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0195","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1002\/eji.1830260905","article-title":"Processing of pro-tumor necrosis factor-\u03b1 by venom metalloproteinases: a hypothesis explaining local tissue damage following snake bite","volume":"26","author":"Moura-da-Silva","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0200","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0304-4165(01)00206-9","article-title":"Factor X activator from Vipera lebetina snake venom, molecular characterization and substrate specificity","volume":"1568","author":"Siigur","year":"2001","journal-title":"Biochim. Biophys. Acta (BBA)"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000727","article-title":"Mechanisms of vascular damage by hemorrhagic snake venom metalloproteinases: tissue distribution and in situ hydrolysis","volume":"4","author":"Baldo","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0210","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.abb.2006.09.018","article-title":"Novel insights into capillary vessel basement membrane damage by snake venom hemorrhagic metalloproteinases: a biochemical and immunohistochemical study","volume":"455","author":"Escalante","year":"2006","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0215","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.jprot.2011.03.026","article-title":"Key events in microvascular damage induced by snake venom hemorrhagic metalloproteinases","volume":"74","author":"Escalante","year":"2011","journal-title":"J. Proteome"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/toxins8010002","article-title":"Scorpions from Mexico: from species diversity to venom complexity","volume":"8","author":"Santibanez-Lopez","year":"2015","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0225","first-page":"242","article-title":"Fauna and geographical distribution of scorpions in Ilam Province, South Western Iran","volume":"11","author":"Sharifinia","year":"2017","journal-title":"J. Arthropod. Borne Dis."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0230","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.toxicon.2014.11.233","article-title":"Scorpion venom components as potential candidates for drug development","volume":"93","author":"Ortiz","year":"2015","journal-title":"Toxicon"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0235","doi-asserted-by":"crossref","first-page":"958797","DOI":"10.1155\/2013\/958797","article-title":"Scorpion peptides: potential use for new drug development","volume":"2013","author":"Hmed","year":"2013","journal-title":"J. Toxicol."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0240","first-page":"287","article-title":"Scorpion toxins specific for Na+\u2212channels","volume":"264","author":"Possani","year":"1999","journal-title":"FEBS J."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0245","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0006-291X(80)80082-9","article-title":"Two types of scorpion neurotoxins characterized by their binding to two separate receptor sites on rat brain synaptosomes","volume":"95","author":"Jover","year":"1980","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0250","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.toxicon.2005.11.013","article-title":"Genetic mechanisms of scorpion venom peptide diversification","volume":"47","author":"Zhijian","year":"2006","journal-title":"Toxicon"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0255","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/15216540500058899","article-title":"Scorpion venom peptides without disulfide bridges","volume":"57","author":"Zeng","year":"2005","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0260","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.peptides.2013.10.021","article-title":"Scorpion venom peptides with no disulfide bridges: a review","volume":"51","author":"Almaaytah","year":"2014","journal-title":"Peptides"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0265","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.peptides.2003.12.003","article-title":"Identification and functional characterization of novel scorpion venom peptides with no disulfide bridge from Buthus martensii Karsch","volume":"25","author":"Zeng","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0270","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.toxicon.2013.07.012","article-title":"Scorpion venom components that affect ion-channels function","volume":"76","author":"Quintero-Hern\u00e1ndez","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0275","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.biochi.2013.01.015","article-title":"Molecular cloning and biochemical characterization of the first Na+-channel \u03b1-type toxin peptide (Acra4) from Androctonus crassicauda scorpion venom","volume":"95","author":"Caliskan","year":"2013","journal-title":"Biochimie"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0280","first-page":"1113","article-title":"Ueber das Zustandekommen der Diphtherie-Immunitat und der Tetanus-Immunitat bei thieren","volume":"16","author":"Behring","year":"1890","journal-title":"Milestones Microbiol."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0285","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40409-016-0074-7","article-title":"Paths to the discovery of antivenom serotherapy in France","volume":"22","author":"Bochner","year":"2016","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0290","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0140-6736(09)61754-2","article-title":"Snake bite","volume":"375","author":"Warrell","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0295","series-title":"Cognitive Impairment in Schizophrenia","article-title":"Handbook of experimental pharmacology","author":"Keefe","year":"2012"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0300","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0041-0101(02)00209-X","article-title":"The impact of a low dose, low volume, multi-site immunization on the production of therapeutic antivenoms in Thailand","volume":"41","author":"Sriprapat","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0305","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/S0041-0101(01)00108-8","article-title":"Production of potent polyvalent antivenom against three elapid venoms using a low dose, low volume, multi-site immunization protocol","volume":"39","author":"Chotwiwatthanakun","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0310","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.vaccine.2003.09.046","article-title":"Development of venom toxin-specific antibodies by DNA immunisation: rationale and strategies to improve therapy of viper envenoming","volume":"22","author":"Harrison","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0315","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.2174\/1381612822666160623073438","article-title":"From fangs to pharmacology: the future of snakebite envenoming therapy","volume":"22","author":"Laustsen","year":"2016","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0320","series-title":"Principles of Toxicology: Environmental and Industrial Applications","author":"Dayan","year":"2001"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0325","series-title":"Industrial Production and Quality Control of Snake Antivenoms, Toxinology","first-page":"1","volume":"2021","author":"Le\u00f3n","year":"2014"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0330","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.toxicon.2009.01.032","article-title":"Death following coral snake bite in the United States\u2013first documented case (with ELISA confirmation of envenomation) in over 40 years","volume":"53","author":"Norris","year":"2009","journal-title":"Toxicon"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0335","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.jprot.2011.05.027","article-title":"Ending the drought: new strategies for improving the flow of affordable, effective antivenoms in Asia and Africa","volume":"74","author":"Williams","year":"2011","journal-title":"J. Proteome"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0340","series-title":"Therapeutic Antibodies","first-page":"3","article-title":"Historical development of monoclonal antibody therapeutics","author":"Nissim","year":"2008"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0345","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/pbi.12823","article-title":"A synthetic biology approach for consistent production of plant-made recombinant polyclonal antibodies against snake venom toxins","volume":"16","author":"Julve Parreno","year":"2018","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179902","article-title":"Monoclonal antibodies expression improvement in CHO cells by PiggyBac transposition regarding vectors ratios and design","volume":"12","author":"Ahmadi","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0355","doi-asserted-by":"crossref","first-page":"44246","DOI":"10.1038\/srep44246","article-title":"Proteomic analysis of host cell protein dynamics in the culture supernatants of antibody-producing CHO cells","volume":"7","author":"Park","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0360","series-title":"MAbs","first-page":"9","article-title":"The therapeutic monoclonal antibody market","volume":"vol. 7","author":"Ecker","year":"2015"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0365","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/apt.13653","article-title":"Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitis","volume":"44","author":"Sandborn","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0370","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1183\/13993003.01030-2015","article-title":"FG-3019 anti-connective tissue growth factor monoclonal antibody: results of an open-label clinical trial in IPF","volume":"47","author":"Raghu","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171205","article-title":"A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myeloma","volume":"12","author":"Wichert","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0380","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jprot.2008.12.007","article-title":"Human monoclonal ScFv neutralize lethal Thai cobra, Naja kaouthia, neurotoxin","volume":"72","author":"Kulkeaw","year":"2009","journal-title":"J. Proteomics"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0385","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3390\/toxins9110347","article-title":"Single chain antibody fragment against venom from the snake Daboia russelii formosensis","volume":"9","author":"Lee","year":"2017","journal-title":"Toxins"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0390","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.toxicon.2014.05.017","article-title":"A neutralizing recombinant single chain antibody, scFv, against BaP1, A PI hemorrhagic metalloproteinase from Bothrops asper snake venom","volume":"87","author":"Castro","year":"2014","journal-title":"Toxicon"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0395","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/363446a0","article-title":"Naturally occurring antibodies devoid of light chains","volume":"363","author":"Hamers-Casterman","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0400","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1146\/annurev-biochem-063011-092449","article-title":"Nanobodies: natural single-domain antibodies","volume":"82","author":"Muyldermans","year":"2013","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0405","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.vetimm.2008.10.299","article-title":"Camelid immunoglobulins and nanobody technology","volume":"128","author":"Muyldermans","year":"2009","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0410","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10555-005-6193-1","article-title":"Prokaryotic expression of antibodies","volume":"24","author":"Arbabi-Ghahroudi","year":"2005","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0415","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.toxicon.2017.02.008","article-title":"Thermal stabilization of anti-\u03b1-cobratoxin single domain antibodies","volume":"129","author":"Anderson","year":"2017","journal-title":"Toxicon"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0420","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jmb.2008.01.022","article-title":"Disulfide bond introduction for general stabilization of immunoglobulin heavy-chain variable domains","volume":"377","author":"Saerens","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0425","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/j.bbagen.2017.06.014","article-title":"Exploiting sequence and stability information for directing nanobody stability engineering","volume":"1861","author":"Kunz","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0430","series-title":"MAbs","first-page":"693","article-title":"Camelid Ig V genes reveal significant human homology not seen in therapeutic target genes, providing for a powerful therapeutic antibody platform","volume":"vol. 7","author":"Klarenbeek","year":"2015"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0435","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.3389\/fimmu.2017.01603","article-title":"Nanobodies and nanobody-based human heavy chain antibodies as anti-tumor therapeutics","volume":"8","author":"Bannas","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0440","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.ddtec.2010.03.002","article-title":"Nanobodies\u2013from llamas to therapeutic proteins","volume":"7","author":"Kolkman","year":"2010","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0445","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1042\/BA20060071","article-title":"Production and characterization of anti-(mucin MUC1) single-domain antibody in tobacco (Nicotiana tabacum cultivar Xanthi)","volume":"47","author":"Ismaili","year":"2007","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0450","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005361","article-title":"Recombinant snakebite antivenoms: a cost-competitive solution to a neglected tropical disease?","volume":"11","author":"Laustsen","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0455","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2967\/jnumed.115.162024","article-title":"Phase I study of 68Ga-HER2-nanobody for PET\/CT assessment of HER2 expression in breast carcinoma","volume":"57","author":"Keyaerts","year":"2016","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0460","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2967\/jnumed.115.171306","article-title":"Preclinical evaluation of 18F-labeled Anti-HER2 nanobody conjugates for imaging HER2 receptor expression by immuno-PET","volume":"57","author":"Vaidyanathan","year":"2016","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0465","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/ehjci\/jev346","article-title":"Targeting of vascular cell adhesion molecule-1 by 18F-labelled nanobodies for PET\/CT imaging of inflamed atherosclerotic plaques","volume":"17","author":"Bala","year":"2016","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0470","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1158\/1535-7163.MCT-11-0891","article-title":"Nanobodies targeting the hepatocyte growth factor: potential new drugs for molecular cancer therapy","volume":"11","author":"Vosjan","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0475","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jconrel.2014.12.039","article-title":"Tumor-penetrating peptide fused EGFR single-domain antibody enhances cancer drug penetration into 3D multicellular spheroids and facilitates effective gastric cancer therapy","volume":"200","author":"Sha","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0480","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejps.2015.05.020","article-title":"A tumor-penetrating recombinant protein anti-EGFR-iRGD enhance efficacy of paclitaxel in 3D multicellular spheroids and gastric cancer in vivo","volume":"77","author":"Sha","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0485","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/ejh.12185","article-title":"Anti-c-MET Nanobody\u00ae\u2013a new potential drug in multiple myeloma treatment","volume":"91","author":"Sl\u00f8rdahl","year":"2013","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0490","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1128\/AAC.01802-15","article-title":"Generation and characterization of ALX-0171, a potent novel therapeutic nanobody for the treatment of respiratory syncytial virus infection","volume":"60","author":"Detalle","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150958","article-title":"Genetic passive immunization with adenoviral vector expressing chimeric nanobody-Fc molecules as therapy for genital infection caused by Mycoplasma hominis","volume":"11","author":"Burmistrova","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0500","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf8463","article-title":"Nanobodies that block gating of the P2X7 ion channel ameliorate inflammation","volume":"8","author":"Danquah","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0505","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1074\/jbc.M114.617787","article-title":"Generation and characterization of small single domain antibodies inhibiting human tumor necrosis factor receptor 1","volume":"290","author":"Steeland","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0510","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13075-015-0651-0","article-title":"The preclinical pharmacology of the high affinity anti-IL-6R Nanobody\u00ae ALX-0061 supports its clinical development in rheumatoid arthritis","volume":"17","author":"Van Roy","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0515","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/15569543.2016.1244552","article-title":"Development of a recombinant camelid specific diabody against the heminecrolysin fraction of Hemiscorpius lepturus scorpion","volume":"36","author":"Bagheri","year":"2017","journal-title":"Toxin Rev."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0520","series-title":"The Coming of Age of Engineered Multivalent Antibodies","author":"Alvarez-Vallina","year":"2015"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0525","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1096\/fj.09-148213","article-title":"A bispecific nanobody to provide full protection against lethal scorpion envenoming","volume":"24","author":"Hmila","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0530","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/pbi.12094","article-title":"Fusion of an Fc chain to a VHH boosts the accumulation levels in Arabidopsis seeds","volume":"11","author":"Buck","year":"2013","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0535","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1016\/j.molimm.2008.04.011","article-title":"VHH, bivalent domains and chimeric heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI\u2032","volume":"45","author":"Hmila","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0540","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1158\/0008-5472.CAN-03-3935","article-title":"Efficient cancer therapy with a nanobody-based conjugate","volume":"64","author":"Cortez-Retamozo","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0545","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nmeth953","article-title":"Targeting and tracing antigens in live cells with fluorescent nanobodies","volume":"3","author":"Rothbauer","year":"2006","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0550","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/cgt.2016.76","article-title":"Intrabody targeting vascular endothelial growth factor receptor-2 mediates downregulation of surface localization","volume":"24","author":"Alirahimi","year":"2017","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0555","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/protein\/gzr037","article-title":"Development of Cys38 knock-out and humanized version of NbAahII10 nanobody with improved neutralization of AahII scorpion toxin","volume":"24","author":"Ben Abderrazek","year":"2011","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0560","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1096\/fj.13-247478","article-title":"A camelid antibody candidate for development of a therapeutic agent against Hemiscorpius lepturus envenomation","volume":"28","author":"Yardehnavi","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0565","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.molimm.2015.10.002","article-title":"Development of protective agent against Hottentotta saulcyi venom using camelid single-domain antibody","volume":"68","author":"Darvish","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0570","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151363","article-title":"Inhibition of the myotoxicity induced by Bothrops jararacussu venom and isolated phospholipases A 2 by specific camelid single-domain antibody fragments","volume":"11","author":"Prado","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0575","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069495","article-title":"In vivo neutralization of \u03b1-cobratoxin with high-affinity llama single-domain antibodies (VH Hs) and a VH H-Fc antibody","volume":"8","author":"Richard","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0580","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3390\/toxins4070554","article-title":"Humanized-single domain antibodies (VH\/VHH) that bound specifically to Naja kaouthia phospholipase A2 and neutralized the enzymatic activity","volume":"4","author":"Chavanayarn","year":"2012","journal-title":"Toxins"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0585","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jprot.2015.02.012","article-title":"Venomics, lethality and neutralization of Naja kaouthia (monocled cobra) venoms from three different geographical regions of Southeast Asia","volume":"120","author":"Tan","year":"2015","journal-title":"J. Proteome"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0590","first-page":"31","article-title":"Biochemical and biological characterization of Naja kaouthia venom from North-East India and its neutralization by polyvalent antivenom","volume":"4","author":"Das","year":"2013","journal-title":"J. Venom Res."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0595","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.toxicon.2015.03.001","article-title":"Snake venomics of monocled cobra (Naja kaouthia) and investigation of human IgG response against venom toxins","volume":"99","author":"Laustsen","year":"2015","journal-title":"Toxicon"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0600","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1600-0404.2011.01593.x","article-title":"Neurological complications of venomous snake bites: a review","volume":"125","author":"Del Brutto","year":"2012","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0605","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069495","article-title":"In vivo neutralization of \u03b1-cobratoxin with high-affinity llama single-domain antibodies (VHHs) and a VHH-Fc antibody","volume":"8","author":"Richard","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0610","series-title":"Seminars in Neurology","first-page":"52","article-title":"Neurotoxic snake envenoming","volume":"vol. 10","author":"Minton","year":"1990"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0615","first-page":"447","article-title":"Clinico-pathological studies on snakebites in Taiwan","volume":"71","author":"Kuo","year":"1972","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0620","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1580\/1080-6032(1997)008[0020:MOTCBW]2.3.CO;2","article-title":"Management of Thai cobra bites with a single bolus of antivenin","volume":"8","author":"Pochanugool","year":"1997","journal-title":"Wilderness Environ. Med."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0625","first-page":"577","article-title":"Influential factors affecting prognosis of snakebite patients management: Kaohsiung Chang Gung Memorial Hospital experience","volume":"23","author":"Liao","year":"2000","journal-title":"Chang Gung Med. J."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0630","doi-asserted-by":"crossref","first-page":"876","DOI":"10.4269\/ajtmh.16-0842","article-title":"Bites by the Monocled Cobra, Naja kaouthia, in Chittagong Division, Bangladesh: epidemiology, clinical features of envenoming and management of 70 identified cases","volume":"96","author":"Faiz","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0635","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.bbagen.2006.04.008","article-title":"Expression of recombinant human antibody fragments capable of inhibiting the phospholipase and myotoxic activities of Bothrops jararacussu venom","volume":"1760","author":"Tamarozzi","year":"2006","journal-title":"Biochim. Biophys. Acta (BBA)"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0640","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/0006-3002(63)90792-3","article-title":"The substrate specificity of phospholipase A","volume":"70","author":"Van Deenen","year":"1963","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0645","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/981923","article-title":"Alkylation of histidine residues of Bothrops jararacussu venom proteins and isolated phospholipases: a biotechnological tool to improve the production of antibodies","volume":"2014","author":"Guimar\u00e3es","year":"2014","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0650","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.toxicon.2003.11.005","article-title":"Skeletal muscle degeneration induced by venom phospholipases A 2: insights into the mechanisms of local and systemic myotoxicity","volume":"42","author":"Guti\u00e9rrez","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0655","doi-asserted-by":"crossref","first-page":"7326","DOI":"10.1074\/jbc.M410588200","article-title":"A molecular mechanism for Lys49-phospholipase A2 activity based on ligand-induced conformational change","volume":"280","author":"Ambrosio","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0660","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0300-9084(00)01150-0","article-title":"Myotoxic phospholipases A 2 in Bothrops snake venoms: effect of chemical modifications on the enzymatic and pharmacological properties of bothropstoxins from Bothrops jararacussu","volume":"82","author":"Andri\u00e3o-Escarso","year":"2000","journal-title":"Biochimie"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0665","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.biochi.2004.02.002","article-title":"Analysis of Bothrops jararacussu venomous gland transcriptome focusing on structural and functional aspects: I\u2014gene expression profile of highly expressed phospholipases A 2","volume":"86","author":"Kashima","year":"2004","journal-title":"Biochimie"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0670","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151363","article-title":"Inhibition of the myotoxicity induced by Bothrops jararacussu venom and isolated phospholipases A2 by specific camelid single-domain antibody fragments","volume":"11","author":"Prado","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0675","series-title":"Scorpion Venoms","first-page":"139","article-title":"Recombinant neutralizing antibodies, a new generation of antivenoms","author":"Rodr\u00edguez","year":"2015"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0680","doi-asserted-by":"crossref","first-page":"14149","DOI":"10.1074\/jbc.M112.348912","article-title":"Diabody mixture providing full protection against experimental scorpion envenoming with crude Androctonus australis venom","volume":"287","author":"Di Tommaso","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0685","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.toxicon.2003.10.021","article-title":"Immunized camel sera and derived immunoglobulin subclasses neutralizing Androctonus australis hector scorpion toxins","volume":"42","author":"Meddeb-Mouelhi","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0690","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1042\/BJ20090697","article-title":"Identification of potent nanobodies to neutralize the most poisonous polypeptide from scorpion venom","volume":"424","author":"Abderrazek","year":"2009","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0695","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/protein\/gzr037","article-title":"Development of Cys38 knock-out and humanized version of NbAahII10 nanobody with improved neutralization of AahII scorpion toxin","volume":"24","author":"Ben Abderrazek","year":"2011","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0700","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.toxicon.2007.07.018","article-title":"An epidemiological and a clinical study on scorpionism by the Iranian scorpion Hemiscorpius lepturus","volume":"50","author":"Pipelzadeh","year":"2007","journal-title":"Toxicon"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0705","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.toxicon.2016.11.261","article-title":"The first report on transcriptome analysis of the venom gland of Iranian scorpion, Hemiscorpius lepturus","volume":"125","author":"Kazemi-Lomedasht","year":"2017","journal-title":"Toxicon"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0710","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0049-3848(01)00254-7","article-title":"In vivo and in vitro cytotoxicity of brown spider venom for blood vessel endothelial cells","volume":"102","author":"Veiga","year":"2001","journal-title":"Thromb. Res."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0715","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.toxicon.2010.05.008","article-title":"Enzymatic analysis of Hemiscorpius lepturus scorpion venom using zymography and venom-specific antivenin","volume":"56","author":"Seyedian","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0720","first-page":"73","article-title":"The review of status of scorpion sting in Iran and problems from it","volume":"9","author":"Dehghani","year":"2005","journal-title":"Feyz"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0725","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.toxicon.2011.05.016","article-title":"Heminecrolysin, the first hemolytic dermonecrotic toxin purified from scorpion venom","volume":"58","author":"Borchani","year":"2011","journal-title":"Toxicon"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0730","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/toxins9030102","article-title":"Characteristics and lethality of a novel recombinant dermonecrotic venom phospholipase D from Hemiscorpius lepturus","volume":"9","author":"Torabi","year":"2017","journal-title":"Toxins"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0735","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.toxicon.2009.09.012","article-title":"A review of epidemiological, clinical and in vitro physiological studies of envenomation by the scorpion Hemiscorpius lepturus (Hemiscorpiidae) in Iran","volume":"55","author":"Jalali","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0740","first-page":"1","article-title":"On two subspecies of Mesobuthus eupeus (CL Koch, 1839) in Turkey (Scorpiones: Buthidae)","volume":"2011","author":"Kova\u0159\u00edk","year":"2011","journal-title":"Euscorpius"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0745","doi-asserted-by":"crossref","first-page":"S217","DOI":"10.12980\/APJTB.4.2014C1323","article-title":"Scorpion fauna and epidemiological aspects of scorpionism in southeastern Iran","volume":"4","author":"Nejati","year":"2014","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0750","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1016\/j.febslet.2005.06.052","article-title":"OD1, the first toxin isolated from the venom of the scorpion Odonthobuthus doriae active on voltage-gated Na+ channels","volume":"579","author":"Jalali","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0755","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0300-9084(00)01167-6","article-title":"Peptides and genes coding for scorpion toxins that affect ion-channels","volume":"82","author":"Possani","year":"2000","journal-title":"Biochimie"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0760","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.toxicon.2010.02.012","article-title":"Antivenom: the most cost-effective treatment in the world?","volume":"55","author":"Brown","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0765","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.toxicon.2016.01.063","article-title":"Camelid antivenom development and potential in vivo neutralization of Hottentotta saulcyi scorpion venom","volume":"113","author":"Darvish","year":"2016","journal-title":"Toxicon"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0770","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.nbt.2017.05.005","article-title":"Guiding recombinant antivenom development by omics technologies","volume":"45","author":"Laustsen","year":"2017","journal-title":"New Biotechnol."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0775","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40409-017-0117-8","article-title":"Strategies in \u2018snake venomics\u2019 aiming at an integrative view of compositional, functional, and immunological characteristics of venoms","volume":"23","author":"Lomonte","year":"2017","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0780","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.nbt.2017.05.005","article-title":"Guiding recombinant antivenom development by omics technologies","volume":"45","author":"Laustsen","year":"2017","journal-title":"New Biotechnol."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0785","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030150","article-title":"Confronting the neglected problem of snake bite envenoming: the need for a global partnership","volume":"3","author":"Guti\u00e9rrez","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0790","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0140-6736(09)61159-4","article-title":"The global snake bite initiative: an antidote for snake bite","volume":"375","author":"Williams","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0795","first-page":"865","article-title":"Herbs and herbal constituents active against snake bite","volume":"48","author":"Gomes","year":"2010","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0800","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nature.2016.19755","article-title":"Synthetic biology tackles antivenom: artificial antibodies could ease global snakebite burden","volume":"532","author":"Arnold","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0805","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0041-0101(98)00145-7","article-title":"Neutralization of local tissue damage induced by Bothrops asper (terciopelo) snake venom","volume":"36","author":"Guti\u00e9rrez","year":"1998","journal-title":"Toxicon"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0810","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0041-0101(98)00144-5","article-title":"Pharmacokinetics of 125 I-labelled IgG, F (ab') 2 and Fab fractions of scorpion and snake antivenins: merits and potential for therapeutic use","volume":"36","author":"Ismail","year":"1998","journal-title":"Toxicon"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0815","first-page":"885","article-title":"The management of snake bite","volume":"61","author":"Reid","year":"1983","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0820","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/ijc.10212","article-title":"Efficient tumor targeting by single-domain antibody fragments of camels","volume":"98","author":"Cortez-Retamozo","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0825","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.vetimm.2008.10.299","article-title":"Camelid immunoglobulins and nanobody technology","volume":"128","author":"Muyldermans","year":"2009","journal-title":"Vet. Immunol. Immunopathol."},{"issue":"2013","key":"10.1016\/j.bbagen.2018.08.019_bb0830","article-title":"Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery","volume":"40","author":"Kijanka","year":"1718","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0835","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/11717","article-title":"Therapeutic antibody fragments with prolonged in vivo half-lives","volume":"17","author":"Chapman","year":"1999","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0840","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1365-2249.1996.d01-847.x","article-title":"Differential clearance of glycoforms of IgG in normal and autoimmune-prone mice","volume":"106","author":"Newkirk","year":"1996","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0845","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1089\/mab.2014.0051","article-title":"Camel heavy chain polyclonal antibody raised against recombinant murine placental growth factor expressed in Escherichia coli","volume":"34","author":"Arezumand","year":"2015","journal-title":"Monoclon. Antib. Immunodiagn. Immunother."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0850","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/mab.2016.0001","article-title":"Production and characterization of novel camel single domain antibody targeting mouse vascular endothelial growth factor","volume":"35","author":"Kazemi-Lomedasht","year":"2016","journal-title":"Monoclon. Antib. Immunodiagn. Immunother."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0855","doi-asserted-by":"crossref","first-page":"38568","DOI":"10.18632\/oncotarget.16930","article-title":"Novel recombinant immunotoxin of EGFR specific nanobody fused with cucurmosin, construction and antitumor efficiency in vitro","volume":"8","author":"Deng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0860","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.molimm.2016.09.012","article-title":"Identification and characterization of a novel nanobody against human placental growth factor to modulate angiogenesis","volume":"78","author":"Arezumand","year":"2016","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0865","first-page":"1201","article-title":"Preparation and characterization of a novel nanobody against T-cell immunoglobulin and mucin-3 (TIM-3)","volume":"19","author":"Homayouni","year":"2016","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0870","doi-asserted-by":"crossref","first-page":"17004","DOI":"10.1038\/celldisc.2017.4","article-title":"Structural basis of a novel PD-L1 nanobody for immune checkpoint blockade","volume":"3","author":"Zhang","year":"2017","journal-title":"Cell Discov."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0875","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/bab.1226","article-title":"Camelid-derived heavy-chain nanobody against Clostridium botulinum neurotoxin E in Pichia pastoris","volume":"63","author":"Baghban","year":"2016","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.bbagen.2018.08.019_bb0880","doi-asserted-by":"crossref","first-page":"21596","DOI":"10.1074\/jbc.M116.749184","article-title":"A diverse set of single-domain antibodies (VHHs) against the anthrax toxin lethal and edema factors provides a basis for construction of a bispecific agent that protects against anthrax infection","volume":"291","author":"Vrentas","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"2011","key":"10.1016\/j.bbagen.2018.08.019_bb0885","article-title":"A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth","volume":"129","author":"Roovers","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbagen.2018.08.019_bb0890","doi-asserted-by":"crossref","first-page":"20565","DOI":"10.1073\/pnas.1012865107","article-title":"CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells","volume":"107","author":"J\u00e4hnichen","year":"2010","journal-title":"Proc. Natl. Acad. Sci."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030441651830285X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030441651830285X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:05:06Z","timestamp":1759637106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030441651830285X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":178,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S030441651830285X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2018.08.019","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanobodies as novel therapeutic agents in envenomation","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2018.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}